98%
921
2 minutes
20
Background: In treatment planning, beam angle optimization (BAO) refers to the selection of a subset with a given number of beam angles from all available angles that provides the best plan quality. BAO is a NP-hard combinatorial problem. Although exhaustive search (ES) can exactly solve BAO by exploring all possible combinations, ES is very time-consuming and practically infeasible.
Purpose: To the best of our knowledge, (1) no optimization method has been demonstrated that can provide the exact solution to BAO, and (2) no study has validated an optimization method for solving BAO by benchmarking with the optimal BAO solution (e.g., via ES), both of which will be addressed by this work.
Methods: This work considers BAO for proton therapy, for example, the selection of 2-4 beam angles for IMPT. The optimal BAO solution is obtained via ES and serves as the ground truth. A new BAO algorithm, namely angle generation (AG) method, is proposed, and demonstrated to provide nearly-exact solutions for BAO in reference to the ES solution. AG iteratively optimizes the angular set via group-sparsity (GS) regularization, until the planning objective does not decrease further.
Results: Since GS alone can also solve BAO, AG was validated and compared with GS for 2-angle brain, 3-angle lung, and 4-angle brain cases, in reference to the optimal BAO solutions obtained by ES: the AG solution had the rank (1/276, 1/2024, 4/10 626), while the GS solution had the rank (42/276, 279/2024, 4328/10 626).
Conclusions: A new BAO algorithm called AG is proposed and shown to provide substantially improved accuracy for BAO from current methods with nearly-exact solutions to BAO, in reference to the ground truth of optimal BAO solution via ES.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272076 | PMC |
http://dx.doi.org/10.1002/mp.16392 | DOI Listing |
J Dermatolog Treat
December 2025
Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Background: Bullous pemphigoid (BP) is a common autoimmune subepidermal bullous disease. Dupilumab, an IL-4/IL-13 inhibitor, represents a novel therapeutic approach for BP, but real-world long-term data in super-elderly patients are limited.
Methods: This retrospective, single-center observational study included super-elderly BP patients (≥80 years) receiving dupilumab monotherapy from September 2022 to September 2024.
BMC Psychiatry
September 2025
Department of Cardiovascular, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Jiangxi, Nanchang, 330006, China.
Anal Bioanal Chem
September 2025
School of Artificial Intelligence, Hangzhou Dianzi University, Hangzhou, 310018, China.
The prompt and accurate identification of pathogenic bacteria is crucial for mitigating the transmission of infections. Conventional detection methods face limitations, including lengthy processing, complex sample pretreatment, high instrumentation costs, and insufficient sensitivity for rapid on-site screening. To address these challenges, an aptamer (Apt)-sensor based on functionalized magnetic nanoparticles (MNPs) was developed for detecting Escherichia coli.
View Article and Find Full Text PDFOncogene
September 2025
Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, China.
Br J Anaesth
September 2025
Department of Anaesthesiology, Amsterdam University Medical Centers, location 'AMC', Amsterdam, The Netherlands; Department of Anaesthesiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Background: The relationship between intraoperative end-tidal CO (etCO) levels and postoperative outcomes remains unclear. We conducted a post hoc analysis of two randomised trials in adults undergoing major surgery under general anaesthesia.
Methods: We re-analysed individual participant data comparing high or low positive end-expiratory pressure with low tidal volume intraoperative ventilation using a merged database derived from two randomised trials in non-obese (PROVHILO: ISRCTN70332574) and obese (PROBESE: NCT02148692) patients.